IGC Pharma, Inc.
IGC · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,821 | -$1,599 | -$1,197 | -$1,829 |
| Dep. & Amort. | $119 | $141 | $154 | $157 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $452 | $455 | $381 |
| Change in WC | -$63 | -$377 | -$296 | -$26 |
| Other Non-Cash | -$325 | -$24 | $154 | $0 |
| Operating Cash Flow | -$2,090 | -$1,407 | -$730 | -$1,317 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$326 | -$8 | -$18 | -$27 |
| Net Acquisitions | -$23 | $0 | $0 | $0 |
| Inv. Purchases | -$25 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $588 | -$124 | -$77 |
| Investing Cash Flow | -$374 | $580 | -$142 | -$104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | $3 | -$1 |
| Stock Issued | $3,111 | $852 | $805 | $346 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$3 | $0 |
| Financing Cash Flow | $3,110 | $851 | $805 | $345 |
| Forex Effect | $5 | $25 | $2 | $0 |
| Net Chg. in Cash | $651 | $49 | -$65 | -$1,076 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $454 | $405 | $470 | $1,546 |
| End Cash | $1,105 | $454 | $405 | $470 |
| Free Cash Flow | -$2,119 | -$1,529 | -$896 | -$1,344 |